In patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS), identification of left main and/or 3-vessel disease (LM/3VD) is crucial for deciding whether to initiate early treatment with clopidogrel, which can increase the risk of surgical bleeding. Methods and Results: On admission, the clinical factors of 501 patients with NSTE-ACS, who underwent coronary angiography, were evaluated. ST-segment shifts and the widest QRS duration were measured on an admission 12-lead electrocardiogram. Ninety-six patients had LM/3VD. Univariate analysis indicated that many factors were related to LM/3VD. On multivariate analysis, QRS duration (odds ratio (OR) 9.04, P<0.01), the degree of ST-segment elevation in lead aVR (OR 7.10, P<0.01), and positive-troponin T (OR 1.52, P<0.05) were independent predictors of LM/3VD. A QRS duration of >90 ms and a ST-segment elevation in lead aVR of ≥0.5 mm best identified LM/3VD. A QRS duration of >90 ms, a ST-segment elevation in lead aVR of ≥0.5 mm, and a positive-troponin T identified LM/3VD with sensitivities of 88%, 76%, and 54% (P<0.01), and specificities of 88%, 86%, and 71% (P<0.01), respectively. Conclusions: A prolonged QRS duration, ST-segment elevation in lead aVR, and a positive-troponin T on admission are useful predictors of LM/3VD in patients with NSTE-ACS. In particular, a maximal QRS duration of >90 ms was the most sensitive predictor of LM/3VD. (Circ J 2009; 73: 1105 -1110 
n early identification of patients with left main and/or 3-vessel disease (LM/3VD) is an important factor in the prognosis and selection of the optimal treatment strategy in patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS). Because combined antiplatelet therapy with aspirin and clopidogrel improves outcomes in patients with NSTE-ACS, 1,2 current international clinical guidelines for the management of NSTE-ACS recommended the early initiation of clopidogrel plus aspirin. 3, 4 However, such a combined therapy can increase the risk of perioperative bleeding events and the need for blood transfusions in patients undergoing early coronary artery bypass graft surgery (CABG). 5, 6 Therefore, clinicians might withhold treatment with clopidogrel until visualization of the coronary anatomy because of concern about operative bleeding in patients likely to require CABG, that is, in such patients, the early initiation of clopidogrel plus aspirin can cause CABG to be postponed until these agents have been eliminated. However, delayed treatment with clopidogrel can increase the risk of cardiac events in patients who do not require CABG. Early (ie, before angiography), accurate, non-invasive identification of patients with LM/3VD in whom CABG is most likely to be indicated is thus a major clinical issue with important therapeutic implications. We have previously demonstrated that ST-segment elevation in lead aVR and positive-troponin T on admission (especially the former) are useful predictors of the risk of LM/3VD in patients with NSTE-ACS, [7] [8] [9] however, QRS duration in previous studies was not considered. Although electrocardiographic assessment of myocardial ischemia is usually based on ST-segment deviation, QRS prolongation has been shown to be more sensitive than ST-segment changes for the detection of myocardial ischemia. [10] [11] [12] Several studies have found that that exercise-induced QRS prolongation is related to the severity and extent of coronary artery disease. 13, 14 However, the relationship between QRS duration on the admission electrocardiogram (ECG) and the severity and extent of coronary artery disease has not been explored previously in patients with NSTE-ACS. In the present study, we investigated clinical factors related to LM/3VD on admission, including QRS duration, in patients with NSTE-ACS who underwent coronary angiography.
Methods

Study Group
We studied 501 consecutive patients (mean age 66±11 years, range 30-92 years; 348 men and 153 women) who were admitted to our coronary care unit and fulfilled the following criteria: (1) typical chest discomfort attributed to (Received October 26, 2008 cardiac ischemia, lasting at least 5 min and occurring within 24 h before hospital admission and involving an unstable pattern of pain, including rest pain, new onset, severe, or frequent angina, or accelerating angina; 6 (2) no conditions precluding the evaluation of QRS duration or ST-segment changes on the ECG (left or right bundle branch block, left ventricular hypertrophy, ventricular pacing, ventricular preexcitation, non-ischemic cardiomyopathy, or antiarrhythmic drugs); (3) fully assessable ECG on admission; and (4) fully assessable angiographic data during hospitalization. We excluded patients with non-ischemic or atypical pain, transient or persistent new ST-segment elevation in leads other than lead aVR, Q-wave acute myocardial infarction on presentation, recent (<6 months) percutaneous coronary intervention, or prior CABG.
In our hospital, we perform emergency cardiac catheterization and revascularization immediately upon admission in patients with unstable hemodynamics caused by ischemic attacks and in whom ischemic attacks cannot be controlled by intensive drug treatment (particularly, patients with decreased cardiac function). In other patients, drug treatment is given after admission to stabilize their condition, and cardiac catheterization is performed after their condition has stabilized. In patients with indications for revascularization, revascularization is performed later. Urgent cardiac catheterization and revascularization are performed in patients with repeated episodes of angina or hemodynamic instability despite intensive drug therapy.
Electrocardiographic Classification
Standard 12-lead ECGs were recorded on admission at a paper speed of 25 mm/s and an amplification of 10 mm/mV. All ECGs were examined by a single investigator who was blinded to all other clinical data. ST-segment shifts were measured 80 ms after the J point for ST-segment depression and 20 ms after this point for ST-segment elevation, using the preceding TP segment as a baseline. 15 ST-segment deviation was considered present if deviation was ≥0.5 mm in any lead. 15, 16 The widest QRS duration on each ECG was manually measured after magnification to 200% by a single investigator who was blinded to all other clinical data. The measurement of the QRS complex began at the left side of the line of junction of the baseline and the Q wave, and ended at the left side of the line of junction of the R or S wave. 17 If there were no Q waves, the measurement was done from the R wave. If there was an obscure S-wave ending, the patient was excluded. Intraobserver variability for the QRS prolongation was 0.8±1.3 ms.
Analysis of Biochemical Markers
A qualitative assay for cardiac-specific troponin T (Roche Diagnostics, detection limit, 0.1 ng/ml of cardiac-specific troponin T) was performed on admission. Troponin T ≥0.1 ng/ml was defined as positive. Blood samples for measuring plasma high-sensitivity C-reactive protein levels were also taken on admission. Brain natriuretic peptide was simultaneously measured in 304 patients by an immunoenzymometric assay using a commercial kit (Shionogi Co, Ltd, Osaka, Japan). Creatine kinase (CK)-MB levels were determined on admission, at 3-h intervals during the first 24 h, and in any patient with suspected reinfarction.
Angiographic Analysis
All patients underwent cardiac catheterization 3 days on average after admission. All coronary angiograms were evaluated by a single investigator who was blinded to all other clinical data. Stenosis of ≥50% in the diameter of the left main coronary artery or stenosis of ≥75% in 1 or more of the major epicardial vessels or their main branches was considered clinically significant.
Clinical Data
Demographic data, risk factors for coronary artery disease, and data from physical examination on admission were collected. Major adverse events such as death, myocardial (re)infarction, or urgent revascularization were also recorded in all patients. Myocardial (re)infarction was diagnosed on the basis of either cardiac enzyme or electrocardiographic evidence. Enzyme evidence of reinfarction was defined as a re-elevation of CK-MB to higher than the upper limit of normal if the previous CK-MB level was in the normal range, or 50% above the previous level if the previous level was above the normal range (ie, a recurrent myocardial infarction in patients with evolving non-Q-wave myocardial infarction on admission). The patients were followed up for 30 days after admission to the hospital.
Statistical Analysis
Continuous data are expressed as mean ± SD, and categorical data as percentages. Analysis of variance was used to assess continuous variables. Chi-squared analysis was used to compare categorical variables. Differences were considered statistically significant at P<0.05. A multivariate logistic regression analysis was used to identify clinical predictors of LM/3VD among the variables associated (P<0.05) with this diagnosis on univariate analysis. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. In addition, the sensitivity, specificity, positive predictive value, negative predictive value, and predictive accuracy of predictors of LM/3VD identified by multivariate analysis were determined. Data were analyzed using SPSS software (Release 10, SPSS Inc, Chicago, IL, USA).
Results
Patient Characteristics
The prevalence of LM/3VD was 19% (LMT 6%), 2-vessel disease 19%, 1-vessel disease 43%, and 0-vessel disease 19%. The baseline characteristics of the subjects are shown in Table 1 . Patients with LM/3VD were older and had higher prevalences of a Killip class of ≥2, prior myocardial infarction, diabetes mellitus, and positive-troponin T; a lower prevalence of smoking; a higher heart rate; and higher levels of CK-MB and brain natriuretic peptide than patients without LM/3VD did. There were no significant differences in sex, systolic blood pressure, symptom onset ≤6 h, prior percutaneous coronary intervention, renal insufficiency (defined as serum creatinine ≥1.5 mg/dl on admission), hypercholesterolemia, or a family history of coronary artery disease between patients with and those without LM/3VD. There was a trend toward a higher rate of hypertension and a higher level of high-sensitivity C-reactive protein in patients with LM/3VD, but the differences did not reach statistical significance. During hospitalization, revascularization procedures, including CABG, were more frequently performed in patients with LM/3VD. Within 30 days after admission, the rate of death was higher in patients with LM/3VD. The rate of (re)infarction was slightly but not significantly higher in patients with LM/3VD. Urgent revascularization, especially urgent CABG, was more fre- OR, odds ratio; CI, confidence interval. Other abbreviations see in Table 1 .
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quently done in patients with LM/3VD.
Electrocardiographic Findings
Patients with LM/3VD had a higher prevalence and a greater amount of ST-segment depression, as well as a greater number of leads with ST-segment depression (excluding lead aVR) than patients without LM/3VD did. Patients with LM/3VD also had a higher prevalence and a greater magnitude of ST-segment elevation in lead aVR. Patients with LM/3VD had a longer QRS duration ( Table 2) .
Predictors of LM/3VD
In the multivariate models, maximal QRS duration was the strongest predictor of LM/3VD, followed by the degree of ST-segment elevation in lead aVR, and positive-troponin T (Table 3, Figure) . The other variables that were associated with LM/3VD (P<0.05) on univariate analysis were not significant predictors of LM/3VD. The sensitivity, specificity, positive predictive value, negative predictive value, and predictive accuracy of a prolonged QRS duration, greater ST-segment elevation in lead aVR, and positive-troponin T for LM/3VD are shown in Table 4 . For each successive 10-ms increase in the definition of prolonged QRS duration (from >80 to >100 ms), there was a stepwise increase in specificity from 38% to 99%, with a corresponding stepwise decrease in sensitivity from 99% to 46%. For each successive 0.5-mm increase in the definition of greater ST-segment elevation in lead aVR (from ≥0.5 to ≥1.5 mm), there was a stepwise increase in specificity from 86% to 99%, with a corresponding stepwise decrease in sensitivity from 76% to 18%. A maximal QRS duration of >90 ms and a ST-segment elevation in lead aVR of ≥0.5 mm were the 2 variables that best identified LM/3VD. Multivariate analysis also showed that maximal QRS duration of >90 ms was the strongest predictor of LM/3VD (OR 33.4, 95%CI 13.5-62.7, P< 0.001), followed by ST-segment elevation in lead aVR of ≥0.5 mm (OR 8.18, 95%CI 2.64-25.3, P<0.001), and positive-troponin T (OR 1.72, 95%CI 1.10-4.12, P<0.05).
Discussion
Our study showed that prolonged QRS duration, STsegment elevation in lead aVR, and positive-troponin T on admission were useful predictors of LM/3VD in patients with NSTE-ACS. In particular, a maximal QRS duration of >90 ms was the most sensitive predictor of LM/3VD. These inexpensive, non-invasive, and easily available markers facilitated the early identification of LM/3VD.
We have previously demonstrated that ST-segment elevation in lead aVR and a positive-troponin T on admission are useful for predicting the risk of LM/3VD in patients with NSTE-ACS. [7] [8] [9] Troponin T on admission is a well-established marker of high risk in patients with NSTE-ACS, 18, 19 whereas ST-segment elevation in lead aVR is more useful for identifying patients with LM/3VD. The results of the Troponin T was positive on admission. The ST-segment elevation in lead aVR was 1.0 mm and the maximal QRS duration was 110 ms in lead V4 on admission ECG. A coronary angiography showed total occlusion at the left anterior descending coronary artery (segment 6) and the left circumflex coronary artery (segment 13), and 90% stenosis at the right coronary artery (segment 1). present study support these findings. Most previous studies assessing the clinical significance of changes on the admission ECG in patients with NSTE-ACS have focused on STsegment depression in leads other than aVR. 16, [19] [20] [21] [22] However, ST-segment elevation in lead aVR was more strongly associated with LM/3VD than ST-segment depression was in other leads in patients with NSTE-ACS, which is consistent with the results of previous studies. [7] [8] [9] 15, 23 In the present study, we included QRS duration in the electrocardiographic analysis, in addition to ST-segment deviation. QRS duration was strongly associated with LM/ 3VD; furthermore, maximal QRS duration of >90 ms was the most sensitive predictor of LM/3VD. Several mechanisms might account for these findings. First, QRS prolongation is most likely caused by extensive ischemia, as indicated by concomitant greater ST-segment deviation. Experimental studies have reported that myocardial ischemia results in slow conduction velocity in ischemic areas. 24, 25 Such decreased conduction velocity is apparently a consequence of regional hyperkalemia, caused by leakage of potassium from ischemic cells. 24, 25 This decreased conduction velocity associated with myocardial ischemia is manifested as QRS prolongation on the surface ECG. Cantor et al reported that QRS duration was more prolonged when the proximal and middle segments of major arteries were occluded than when the distal segments or smaller branches were occluded during percutaneous transluminal coronary angioplasty in humans. 12 Other studies have reported that exercise-induced QRS prolongation without bundle-branch block is directly related to the number of diseased vessels or segmental contraction abnormalities. 13, 14 Several studies have demonstrated that the specificity of QRS prolongation for the detection of myocardial ischemia is similar to that of ST-segment changes, whereas the sensitivity of the former is higher. [10] [11] [12] In the present study, QRS prolongation and ST-segment elevation in lead aVR had similar specificity, but the former was more sensitive, for predicting LM/3VD. The second possible reason for the strong association between QRS duration and LM/3VD is that QRS prolongation might correlate with heart failure. Murkofsky et al reported that a QRS duration of >100 ms on a standard resting 12-lead ECG was a marker of decreased left ventricular function. 26 In the present study, a QRS duration of >100 ms was highly specific (99%), but insensitive (46%) for the prediction of LM/3VD. In addition, QRS prolongation was an independent predictor of LM/3VD after adjusting for heart failure, as evidenced by the worse Killip class. Third, QRS prolongation might reflect of a greater amount of infarction. 27, 28 However, the relationship of QRS prolongation to LM/3VD remained relevant even after adjustment for myocardial damage, as indicated by troponin T or CK-MB.
Study Limitations
Several limitations of the present study should be considered when evaluating the clinical implications of our findings. In routine clinical practice, the measurement of QRS duration on ECGs enlarged to 200% would be troublesome, and the use of computerized ECG techniques might help to standardize measurements of QRS duration. However, this study was retrospective, and ECGs were recorded at a paper speed of 25 mm/s by means of an electrocardiograph without a computer-based automatic analysis system. We therefore could not compare our manually measured values of QRS duration with those automatically measured by computer. This point should be addressed in future studies. Another limitation was that this study was performed at a single center and involved a small number of patients with NSTE-ACS who underwent coronary angiography. Furthermore, patients with known causes of a prolonged QRS duration were excluded.
Clinical Implications
In several previous studies, the prediction of high-risk patients with NSTE-ACS likely to undergo CABG was difficult solely on the basis of baseline clinical characteristics. However, these studies did not consider either ST-segment elevation in lead aVR or QRS duration on the admission ECG. 29, 30 A standard 12-lead ECG on admission is the initial and most widely used method for early risk stratification in patients with NSTE-ACS. 31 Our study showed that QRS prolongation and ST-segment elevation in lead aVR on admission (especially the former) are useful for predicting LM/3VD and can thereby facilitate decision-making, that is, patients likely to have LM/3VD should promptly undergo an angiography and not receive clopidogrel therapy to allow early CABG. Our results emphasize the importance of analyzing QRS duration as well as ST-segment deviation on the admission ECG in the diagnostic workup of patients with NSTE-ACS.
